Identification and treatment of older persons with sarcopenia

Aging Male

Volumn 17, Issue 4, 2014, Pages 199-204

  Lauretani, Fulvio ^a,b   Bautmans, Ivan ^c   De Vita, Francesca ^a,b   Nardelli, Anna ^a,b   Ceda, Gian Paolo ^a,b   Maggio, Marcello ^a,b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Definition; Older persons; Sarcopenia

Indexed keywords

TESTOSTERONE; VITAMIN D;

AGING; ARTICLE; DIET SUPPLEMENTATION; GRIP STRENGTH; HORMONAL THERAPY; HUMAN; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; RESISTANCE TRAINING; SARCOPENIA; SKELETAL MUSCLE; VITAMIN D DEFICIENCY; WALKING SPEED; AGED; FEMALE; GERIATRIC ASSESSMENT; HAND STRENGTH; MALE; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; FEMALE; GERIATRIC ASSESSMENT; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; SARCOPENIA;

EID: 84911882351     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2014.958457     Document Type: Article

References (59)

1. Rosenberg I. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989;50:1231-3.
2. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-63.
3. Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21.
4. Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci 2008;63:829-34.
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412-23.
6. Cherin P, Voronska E, Fraoucene N, de Jaeger C. Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res 2014;26:137-46.
7. Morley JE, Abbatecola AM, Argiles JM, et al; Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011;12:403-9.
8. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiag-nosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12:249-56.
9. Malmstrom TK, Miller DK, Herning MM, Morley JE. Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans. J Cachexia Sarcopenia Muscle 2013;4:179-86.
10. Yu S, Appleton S, Adams R, Chapman I, et al. The impact of low muscle mass definition on the prevalence of sarcopenia in older Australians. BioMed Res Int 2014;2014:361790.
11. Newman AB, Kupelian V, Visser M, et al; Health ABC Study Investigators. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003;51: 1602-9.
12. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. Appl Physiol 2003;95:1851-60.
13. Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014;69: 547-58.
14. McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project. J Gerontol A Biol Sci Med Sci 2014;69:576-83.
15. Alley DE, Shardell MD, Peters KW, et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci 2014;69:559-66.
16. Legrand D, Vaes B, Mathëi C, et al. Muscle strength and physical performance as predictors of mortality, hospitalization, and disability in the oldest old. J Am Geriatr Soc 2014;62:1030-8.
17. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61: 72-7.
18. Savino E, Volpato S, Zuliani G, Guralnik JM. Assessment of mobility status and risk of mobility disability in older persons. Curr Pharm Des 2014;20:3099-113.
19. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011;305:50-8.
20. Newman AB, Simonsick EM, Naydeck BL, et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 2006;295: 2018-26.
21. De Buyser SL, Petrovic M, Taes YE, et al. Physical function measurements predict mortality in ambulatory older men. Eur J Clin Invest 2013;43:379-86.
22. Morley JE, Malmstrom TK. Frailty, sarcopenia, and hormones. Endocrinol Metab Clin North Am 2013;42:391-405.
23. Henwood TR, Keogh JW, Reid N, et al. Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility. J Cachexia Sarcopenia Muscle 2014. [Epub ahead of print].
24. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013;14: 531-2.
25. Landi F, Martone AM, Calvani R, Marzetti E. Sarcopenia risk screening tool: a new strategy for clinical practice. J Am Med Dir Assoc 2014;15:613-4.
26. Cao L, Chen S, Zou C, et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging 2014;18:277-83.
27. Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia?. J Am Med Dir Assoc. 2014;15:649-54.
28. Cooper C, Fielding R, Visser M, et al. Tools in the assessment of sarcopenia. Calcif Tissue Int 2013;93:201-10.
29. Bandinelli S, Milaneschi Y, Ferrucci L. Chair stands test and survival in the older population. J Am Geriatr Soc 2009;57: 2172-3.
30. Cooper R, Strand BH, Hardy R, et al. Physical capability in mid-life and survival over 13 years of follow-up: British birth cohort study. BMJ 2014;348:g2219.
31. Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people: an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009;13: 881-9.
32. Cummings SR, Studenski S, Ferrucci L. A diagnosis of dismobility-giving mobility clinical visibility: a mobility working group recommendation. JAMA 2014;311:2061-2.
33. Ferrucci L, Bandinelli S, Cavazzini C, et al. Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease. Am J Med 2004;116:807-15.
34. Lauretani F, Ceda GP, Pelliccioni P, et al. Approaching neurological diseases to reduce mobility limitations in older persons. Curr Pharm Des 2014;20:3149-64.
35. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014; pii: S2213-8587(14)70034-8. [Epub ahead of print].
36. Lee J, Geller AI, Strasser DC. Analytical review: focus on fall screening assessments. PMR 2013;5:609-21.
37. Kerr GK, Worringham CJ, Cole MH, et al. Predictors of future falls in Parkinson disease. Neurology 2010;75:116-24.
38. Bahat G, Tufan A, Ozkaya H, et al. Relation between hand grip strength, respiratory muscle strength and spirometric measures in male nursing home residents. Aging Male 2014;17:136-40.
39. Maggio M, Lauretani F, Ceda GP. Sex hormones and sarco-penia in older persons. Curr Opin Clin Nutr Metab Care 2013;16: 3-13.
40. Maggio M, Lauretani F, De Vita F, et al. Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. Curr Pharm Des 2014;20:3119-48.
41. Lunenfeld B, Arver S, Moncada I, et al. How to help the aging male? Current approaches to hypogonadism in primary care. Aging Male 2012;15:187-97.
42. Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men-a suggested update. Aging Male 2013;16:143-50.
43. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589-98.
44. Maggio M, Ceda GP, Lauretani F, et al. Gonadal status and physical performance in older men. Aging Male 2011;14:42-7.
45. Lauretani F, Maggio M, Valenti G, et al. Vitamin D in older population: new roles for this 'classic actor'? Aging Male 2010;13: 215-32.
46. Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010;21:1151-4.
47. Beaudart C, Buckinx F, Rabenda V, et al. The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2014. [Epub ahead of print].
48. Liu G, Lu L, Sun Q, et al. Poor vitamin d status is prospectively associated with greater muscle mass loss in middle-aged and elderly Chinese individuals. J Acad Nutr Diet 2014. [Epub ahead of print].
49. Landi F, Laviano A, Cruz-Jentoft AJ. The anorexia of aging: is it a geriatric syndrome? J Am Med Dir Assoc 2010;11:153-6.
50. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996;54:S59-65.
51. Schrader E, Baumgärtel C, Gueldenzoph H, et al. Nutritional status according to mini nutritional assessment is related to functional status in geriatric patients independent of health status. J Nutr Health Aging 2014;18:257-63.
52. Van Roie E, Delecluse C, Coudyzer W, et al. Strength training at high versus low external resistance in older adults: effects on muscle volume, muscle strength, and force-velocity characteristics. Exp Gerontol 2013;48:1351-61.
53. Raymond MJ, Bramley-Tzerefos RE, Jeffs KJ, et al. Systematic review of high-intensity progressive resistance strength training of the lower limb compared with other intensities of strength training in older adults. Arch Phys Med Rehabil 2013;94:1458-72.
54. Keogh JW, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manage 2012;43:96-110.
55. Gaffney-Stomberg E, Insogna KL, Rodriguez NR, Kerstetter JE. Increasing dietary protein requirements in elderly people for optimal muscle and bone health. J Am Geriatr Soc 2009;57:1073-9.
56. Institute of Medicine. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington, DC: The National Academies Press; 2005.
57. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010;11:e391-6.
58. Bahat G, Saka B, Tufan F, et al. Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey. Aging Male 2010;13: 211-14.
59. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009;12:86-90.